All Articles
"Whatever Anything Is it Ought to Begin by Being Personal"

"Whatever Anything Is it Ought to Begin by Being Personal"

24 January, 2013

Research shows that patients are interested in talking about testing. In this Expert Insight, Sanna Jousi discusses how personalized medicine offers the chance for pharma and physicians to reconnect with their patients and put the person back into personalized medicine.|Research shows that patients are interested in talking about testing. In this Expert Insight, Sanna Jousi discusses how personalized medicine offers the chance for pharma and physicians to reconnect with their patients and put the person back into personalized medicine.|Research shows that patients are interested in talking about testing. In this Expert Insight, Sanna Jousi discusses how personalized medicine offers the chance for pharma and physicians to reconnect with their patients and put the person back into personalized medicine.|Research shows that patients are interested in talking about testing. In this Expert Insight, Sanna Jousi discusses how personalized medicine offers the chance for pharma and physicians to reconnect with their patients and put the person back into personalized medicine.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.